Cargando…

Are Oxidized LDL/β2-glycoprotein I Complexes Pathogenic Antigens in Autoimmune-mediated Atherosclerosis?

The oxidative modification of low-density lipoprotein (LDL) in the intima of arteries contributes to the initiation and progression of atherosclerotic lesions. We have previously reported that oxidized LDL (oxLDL) interacts with an endogenous plasma protein, β2-glycoprotein I (β2GPI), to form comple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuura, Eiji, Lopez, Luis R.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270711/ https://www.ncbi.nlm.nih.gov/pubmed/15330445 http://dx.doi.org/10.1080/10446670410001722186

Ejemplares similares

Predictive Value of Oxidized Low-Density Lipoprotein/β(2)-Glycoprotein-I Complexes (oxLDL/β(2)GPI) in Nonautoimmune Atherothrombosis
por: Ames, Paul R. J., et al.
Publicado: (2018)

Is atherosclerosis an autoimmune disease?
por: Matsuura, Eiji, et al.
Publicado: (2014)

Periodontal Pathogens and Atherosclerosis: Implications of Inflammation and Oxidative Modification of LDL
por: Kurita-Ochiai, Tomoko, et al.
Publicado: (2014)

Increased LDL susceptibility to oxidation accelerates future carotid artery atherosclerosis
por: Aoki, Toshinari, et al.
Publicado: (2012)

Modulating Autoimmunity against LDL: Development of a Vaccine against Atherosclerosis
por: Marchini, Timoteo, et al.
Publicado: (2021)

IgG Autoantibodies against β(2)-Glycoprotein I Complexed with a Lipid Ligand Derived from Oxidized Low-Density Lipoprotein are Associated with Arterial Thrombosis in Antiphospholipid Syndrome
por: Lopez, Daniel, et al.
Publicado: (2003)

Proatherogenic Oxidized Low-Density Lipoprotein/β2-Glycoprotein I Complexes in Arterial and Venous Disease
por: Berger, Jeffrey S., et al.
Publicado: (2014)

β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease
por: Rauch, Joyce, et al.
Publicado: (2018)

Rapid and specific detection of oxidized LDL/β2GPI complexes via facile lateral flow immunoassay
por: Tan, Xian Wen, et al.
Publicado: (2020)

Differential Trafficking of Oxidized LDL and Oxidized LDL Immune Complexes in Macrophages: Impact on Oxidative Stress
por: Al Gadban, Mohammed M., et al.
Publicado: (2010)

Effect of immunization against ox-LDL with two different antigens on formation and development of atherosclerosis
por: Asgary, Sedigheh, et al.
Publicado: (2007)

Atherosclerosis: visualising oxidised LDL in zebrafish
Publicado: (2012)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Recycling the LDL receptor to combat atherosclerosis
por: Vos, Dyonne, et al.
Publicado: (2018)

Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis
por: Jiang, Hui, et al.
Publicado: (2022)

Atherosclerosis, Inflammation, and Genetics - And you Thought it Was Just LDL-cholesterol
por: Gowdak, Luis Henrique Wolff
Publicado: (2020)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis
por: Khamis, Ramzi Y, et al.
Publicado: (2016)

Quercetin Attenuates Atherosclerosis via Modulating Oxidized LDL-Induced Endothelial Cellular Senescence
por: Jiang, Yue-Hua, et al.
Publicado: (2020)

Antibodies Against β(2)-Glycoprotein I Complexed With an Oxidised Lipoprotein Relate to Intima Thickening of Carotid Arteries in Primary Antiphospholipid Syndrome
por: Ames, P. R. J., et al.
Publicado: (2006)

Role of urinary H(2)O(2), 8-iso-PGF(2)α, and serum oxLDL/β2GP1 complex in the diabetic kidney disease
por: Sauriasari, Rani, et al.
Publicado: (2022)

Corrigendum: Quercetin Attenuates Atherosclerosis via Modulating Oxidized LDL-Induced Endothelial Cellular Senescence
por: Jiang, Yue-Hua, et al.
Publicado: (2020)

Minimally Oxidized-LDL-Driven Alterations in the Level of Pathological Mediators and Biological Processes in Carotid Atherosclerosis
por: Thankam, Finosh G, et al.
Publicado: (2022)

Novel oxidized LDL-based clinical markers in peritoneal dialysis patients for atherosclerosis risk assessment
por: Papadea, Polyxeni, et al.
Publicado: (2023)

Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS
por: Gerhards, Ramona, et al.
Publicado: (2020)

Oxidized LDL‐dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy
por: Sommariva, Elena, et al.
Publicado: (2021)

Atherosclerosis and Autoimmunity
por: Spinelli, Francesca Romana, et al.
Publicado: (2018)

LDL biochemical modifications: a link between atherosclerosis and aging
por: Alique, Matilde, et al.
Publicado: (2015)

Amygdalin ameliorates the progression of atherosclerosis in LDL receptor-deficient mice
por: Lv, Jianzhen, et al.
Publicado: (2017)

Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL
por: Vekic, Jelena, et al.
Publicado: (2022)

Small Dense LDL Tied to Diabetic Retinopathy-Similarity to Atherosclerosis
por: Hirano, Tsutomu
Publicado: (2022)

Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2023)

Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis
por: Puig, Núria, et al.
Publicado: (2023)

Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β(2)-Glycoprotein I
por: Ioannou, Yiannis, et al.
Publicado: (2011)

Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein
por: Nikolic, Jovan, et al.
Publicado: (2018)

Optimization of Unnicked β2-Glycoprotein I and High Avidity Anti-β2-Glycoprotein I Antibodies Isolation
por: Artenjak, Andrej, et al.
Publicado: (2014)

High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes
por: Lopes-Virella, Maria F., et al.
Publicado: (2012)

IRGM1 regulates oxidized LDL uptake by macrophage via actin-dependent receptor internalization during atherosclerosis
por: Xia, Fucan, et al.
Publicado: (2013)

Inflammation and autoimmunity in atherosclerosis
por: Surma, Stanislaw, et al.
Publicado: (2022)

Hyperhomocysteinemia independently causes and promotes atherosclerosis in LDL receptor-deficient mice
por: Guo, Hang-Yuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2fvlgf5pvr5n3cpq38uouk1q40